CARSON CITY, Nev. -- Nevada's Assembly Health and Human Services Committee conducted a hearing this week on a bill that would reclassify medicines containing pseudoephedrine, making them prescription-only. The proposed law, Assembly Bill 150, is backed by all but seven of the state's 63 lawmakers and would push PSE to a schedule III controlled substance. The bill comes after the federal Combat Methamphetamine Act places sales limits on PSE products and mandated their sale from behind the ...

REGISTER TO VIEW THIS ARTICLE - Register for a Free Account

Why Register for FREE?

Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick.  What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
 

Click here to read the FAQ page if you have any questions (opens in a new window)
 

Attention Paid Print Subscribers:  While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.

Already registered? here.